ダウンロード数: 259

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
14_0159.pdf332.25 kBAdobe PDF見る/開く
タイトル: Ubretidの神経因性膀胱に対する効果および血清β-Glucuronidaseにおよぼす影響
その他のタイトル: Clinical evaluation of Ubretid on neurogenic bladder dysfunction and on high serum beta-glucuronidase
著者: 近藤, 賢  KAKEN_name
内藤, 政男  KAKEN_name
杉浦, 啓之  KAKEN_name
著者名の別形: Kondo, Masaru
Naito, Masao
Sugiura, Keiji
キーワード: Glucuronidase/blood
Humans
Parasympathomimetics/therapeutic use
Pyridines/therapeutic use
Spinal Cord Injuries/complications
Urinary Bladder, Neurogenic/drug therapy
発行日: Feb-1968
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 14
号: 2
開始ページ: 159
終了ページ: 163
抄録: Clinical effects of Ubretid on neurogenic bladder dysfunction were evaluated by cystoadaptometry. Oral administration of Ubretid 5 mg daily for 3 weeks made the hypotonic and the hypertonic bladders to be normotonic in several cases. This is the noteworthy merit of Ubretid distinguished from bethanechol chloride, which could not alter the hypertonic bladder toward normotonic. In many traumatic paraplegics (30 in 49), the serum p-glucuronidase activities were high, over 300 pgjdljhr. This finding was considered as a sign suggesting of abnormal sugar metabolism in this disorders. By oral administration of Ubretid 5 mg daily for a week the high serum p-glucuronidase activities in traumatic paraplegics were reduced to normal in many cases (7 in 12). Diagnostic value of high serum p-glucuronidase in traumatic paraplegics, and therapeutic value to reduce the high serum p-glucuronidase to normal were still entirely unknown.
URI: http://hdl.handle.net/2433/119833
PubMed ID: 5692624
出現コレクション:Vol.14 No.2

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。